- White House eyes replacements for Sarah Sanders
- Hong Kong ex-official urges dropping extradition legislation
- Merkel: Price transparency, home building are answer to German housing shortage
- India set to levy higher tariffs on some U.S. goods next week: sources
- "Remain in Mexico" expansion faces logistical, legal barriers
German chemical and pharmaceutical company Bayer says it plans to invest some 5 billion euros ($5.6 billion) over the next decade in developing “additional methods to combat weeds.”
Friday’s announcement came as Bayer is engaged in legal battles in the U.S. in which plaintiffs claim that subsidiary Monsanto’s Roundup weed killer caused cancer. Rulings in three cases have gone against it.
Continue Reading Below
Bayer argues that studies have established that glyphosate, Roundup’s active ingredient, is safe and made clear Friday that it stands by the product. A company statement said that “while glyphosate will continue to play an important role in agriculture and in Bayer’s portfolio, the company is committed to offering more choices for growers.”
Bayer acquired Monsanto for $63 billion last year.